Darkblight

Darkblight (Druvath’miran Dravith)

Classification: Aetherial Degenerative Syndrome

Affiliated Field: Thaumopathology / Metaphysiology

Definition:

Darkblight is a progressive, degenerative condition resulting from the parasitic corruption of an individual’s endogenous Light Energy (Miran) by invasive Dark Energy (Druvath). It constitutes both a metaphysical and physiological affliction, eroding the fundamental harmonic balance that sustains Mundusian life. The syndrome impacts neurological clarity, emotional regulation, and corporeal integrity, culminating—if untreated—in permanent metaphysical displacement, bodily transformation, or death.

---

Clinical Progression and Symptomatology

Medical diagram showing the first stage of Darkblight.

Phase I – Incipient Disjunction (Commonly: "Early Stage")

Onset Symptoms:

• Cognitive Distortion: Patients report mild to moderate derealization, difficulty concentrating, and transient memory gaps.
• Emotional Dysregulation: Presentations include acute mood instability, detachment, or disproportionate emotional suppression or outbursts.
• Energetic Fatigue: Individuals experience a marked depletion of stamina, spatial disorientation, and increased susceptibility to Light-based aetheric fluctuation.
• Ocular Discoloration: A key diagnostic marker. Irises may lose pigmentation (achromia) or darken towards void-like hues. In some cases, full scleral whitening or shadowing is observed. Notes: This phase may be mistaken for minor aetheric imbalance unless detected via Lightmeasure calibration or through high-sensitivity Aura Readers.

---

Medical diagram showing the second stage of Darkblight.

Phase II – Somatic Conversion and Dissociation (Commonly: "Mid-Stage")

Evident Manifestations:

• Dermal Necrochromia and Fissuring: Skin begins to blacken and develop microfractures; in extreme cases, these split open to reveal semi-viscous, obsidian-hued ichor (commonly termed Blightgall).
• Vascular Aether Deformation: Dark-vein manifestation becomes visible, exhibiting pulsing or creeping patterns along limbs and torso.
• Perceptual Disengagement: Patients experience increasing detachment from reality, speech incoherence, and dulled empathetic responses.
• Environmental Drain: Ambient Light Energy is passively absorbed or destabilized within a 3–5 meter radius of the subject, detectable via standard aetheric instruments.

Notes:

Containment protocols are recommended at this stage. Afflicted individuals are advised to remain within Light-consecrated zones to slow progression.

---

Medical diagram showing the third and final stage of Darkblight.

Phase III – Terminal Blight Ascendancy (Commonly: "Late Stage")

Catastrophic Degeneration:

• Total Light Suppression: Internal Miran fields collapse, rendering the body fully dominated by Druvath influx. Light artifacts and wards cease to function in proximity.
• Ophthalmic Inversion: Complete ocular conversion - sclera blackened, irises and pupils replaced by amorphous violet-dark energy cores.
• Vocal System Failure: Rupture of vocal cords results in total loss of speech; moaning or low-frequency aetheric pulses may be emitted instead.
• Skeletal and Muscular Mutation: Patients may lose bipedal posture. In extreme cases, limbs contort into clawed or talon-like appendages.
• Metamorphic Outcome: If the host survives cellular breakdown, a grotesque transformation akin to lower-order Netherkind may occur. Otherwise, death results in a husk-state—a mindless entity drawn to Light Energy, capable of depleting entire consecrated structures if left unchecked.

Terminal Risk Factors:

• Possibility of becoming an involuntary vessel for the entity known as Rathsern, the Cursed One.
• Transition into a Blighted Host Entity—marked by erratic aggression, rapid spreading of Druvath, and non-reversible mutation.

Treatment Considerations:

As of publication, no universally effective cure has been documented. Light-saturated sanctums, relic-channeling by high-capacity Lightbearers, and relics tied to Saints of Aetheria have shown partial success in halting or reversing progression. Research is ongoing under the auspices of Nai Dargaran's Thaumopathology Department.